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Summary  
 
This large community-based study of risk factors for QuantiFERON-positivity in Mongolian 
schoolchildren reports that household exposure to an index case of pulmonary TB, vitamin D 
deficiency, passive smoking and increasing age are risk factors for Mycobacterium tuberculosis 
infection in childhood. 
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Abstract 
 
Background: There is controversy regarding the potential influence of vitamin D deficiency, exposure 
to environmental tobacco smoke, BCG vaccination, season and body habitus on susceptibility to 
Mycobacterium tuberculosis (MTB) infection. 
 
Methods: We conducted a cross-sectional analysis to identify determinants of a positive 
QuantiFERON®-TB Gold (QFT) assay result in children aged 6-13 years attending 18 schools in 
Ulaanbaatar, Mongolia. Data relating to potential risk factors for MTB infection were collected by 
questionnaire, physical examination and determination of serum 25-hydroxyvitamin D (25[OH]D) 
concentrations. Risk ratios were calculated using generalized estimating equations with adjustment for 
potential confounders, and population attributable fractions (PAFs) were calculated for modifiable risk 
factors identified. 
 
Results: 946/9,810 (9.6%) participants had a positive QFT result. QFT-positivity was independently 
associated with household exposure to pulmonary TB (adjusted risk ratio [aRR] 4.75, 95% CI 4.13-5.46, 
P<0.001; PAF 13.1%, 95% CI 11.1%-15.0%), vitamin D deficiency (aRR 1.23, 95% CI 1.08-1.40, 
P=0.002; PAF 5.7%, 1.9%-9.3%), exposure to environmental tobacco smoke (one indoor smoker, aRR 
1.19, 95% CI 1.04-1.35; two or more indoor smokers, aRR 1.30, 95% CI 1.02-1.64; P for trend, 0.006; 
PAF 7.2%, 95% CI 2.2%-12.0%) and increasing age (aRR per additional year 1.14, 95% CI 1.10-1.19, 
P<0.001). No statistically significant independent association was seen for presence of a BCG scar, 
season of sampling or body mass index. 
 
Conclusions: Our findings underline the importance of contact tracing in TB-exposed households as a 
strategy to identify MTB-infected children. Vitamin D deficiency and exposure to environmental 
tobacco smoke may be modifiable risk factors for MTB infection.  
 
Keywords: Latent tuberculosis infection; environmental tobacco smoke; BCG vaccine; Vitamin D 
Standardization Program (VDSP). 
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INTRODUCTION 
 
Mycobacterium tuberculosis (MTB) infection in children necessarily arises from recent transmission: 
this group therefore represents a sentinel population for infectious tuberculosis. Population-based cross-
sectional studies to estimate the prevalence and determinants of MTB infection in children living in 
high-incidence settings can inform tuberculosis control programs by allowing estimates of on-going 
transmission and identifying risk factors for infection that are potentially amenable to intervention. 
 
Exposure to an infectious index case and increasing age are well recognized risk factors for MTB 
infection in children that have been demonstrated in numerous settings [1]. The evidence for other 
potential risk factors is less consistent however. Specifically, some studies have reported associations 
with lack of BCG vaccination [2, 3], exposure to environmental tobacco smoke [4], vitamin D 
deficiency [5], winter and spring season [6] and lower body mass index [7] while others have found no 
such associations [8-10]. Existing studies in the literature are variously limited by lack of power, low 
participation rates, use of the tuberculin skin test to diagnose MTB infection (which may yield false 
positive results in BCG-vaccinated individuals), restriction to household contacts, and insufficiently 
detailed information on potential confounders, all of which may underlie the heterogeneity of results 
seen when their results are meta-analyzed [11-13]. Additional studies addressing these limitations are 
therefore needed to clarify whether or not these factors influence risk of MTB infection. 
 
An opportunity to undertake such a study recently arose in the context of screening for a community-
based Phase 3 clinical trial with very broad eligibility criteria that enrolled primary schoolchildren living 
in Ulaanbaatar, Mongolia [14], where BCG is administered at birth only. A total of 9,814 children 
underwent screening for MTB infection using the QuantiFERON TB Gold test. Comprehensive data 
relating to potential susceptibility factors were collected, and multivariable analyses were performed to 
identify those that were independently associated with increased risk of MTB infection. Population 
attributable fractions (PAF) were then calculated for modifiable risk factors identified.  
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METHODS AND MATERIALS 
Study design, setting and ethical approval 
We conducted a cross-sectional analysis of baseline data from children attending eighteen public 
schools located in six districts of Ulaanbaatar, Mongolia (Bayanzurkh, Songino-Kharkhan, Bayangol, 
Khan-Uul, Chingeltei and Sukhbaatar) who were being screened for participation in a randomized 
controlled trial of vitamin D supplementation for the prevention of MTB infection.[14] Mongolia is an 
East Asian country situated between China and Russia with a population of approximately 3.1 million 
people, of whom 1.2 million (39%) reside in the capital city, Ulaanbaatar. School attendance is 
mandatory for children aged 6-16 years. Incidence of active tuberculosis in Mongolia is estimated at 
428 cases per 100,000 population per annum [15] and prevalence of HIV infection is very low at 0.02% 
[16]. The study was approved by Institutional Review Boards at the Mongolian Ministry of Health, the 
Mongolian National University and the Harvard T. H. Chan School of Public Health, USA (IRB reference 
number 14-0513). 
 
Participants 
Eligibility criteria were as for the clinical trial for which children were being screened.[14] Inclusion 
criteria were age 6-13 years at screening; provision of written informed assent to participate by the 
child; and provision of written informed consent for the child to participate from his/her parent/guardian. 
Exclusion criteria were known HIV sero-positivity, primary hyperparathyroidism, sarcoidosis or previous 
active or latent tuberculosis; taking cytotoxic therapy or other immunosuppressant medication, enzyme-
inducing anticonvulsant therapy, cardiac glycoside, any preparation containing 1-alpha-hydroxylated 
vitamin D or vitamin D supplementation of >10 micrograms/day; planning to move away from 
Ulaanbaatar within 4 years of enrollment; and presence of clinical signs of rickets, assessed by school 
doctors who checked for leg bowing, knock knees, pectus carinatum and thickened wrists and ankles. 
 
Data Collection and Measurements 
Fieldworkers collected information from each child’s parent for the following variables using an 
electronic questionnaire on the RedCAP database: age, sex, highest education level attained by either 
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/advance-article-abstract/doi/10.1093/cid/ciy975/5210883 by guest on 28 N
ovem
ber 2018
 6 
 
parent, type of residence, monthly household income, home ownership, number of people per room, 
indoor tobacco smoking in the household, active smoking by the child themselves, presence of an 
index case of pulmonary TB living in the household during the child’s lifetime, and the average amount 
of time the child spends outdoors per day. Height was measured to the nearest 0.1 cm using a portable 
stadiometer (SECA, Hamburg, Germany). Weight was measured to the nearest 0.1 kg using a Digital 
Floor Scale (SECA). Body mass index (BMI) was calculated using the formula BMI = weight (kg) / 
(height [m]2). Percent body fat was estimated using a body composition analyzer (SC-331S, Tanita, 
Tokyo, Japan). School doctors ascertained the BCG status of participating children by clinical 
examination for a vaccination scar. One ml of venous blood was drawn into nil, TB antigen and mitogen 
QuantiFERON-TB Gold High Altitude tubes (Qiagen, Hilden, Germany), which were processed as 
described below. Children with positive QuantiFERON-TB Gold results were referred to the Mongolia 
National Centre for Communicable Disease for clinical and radiographic screening for active TB. 
QuantiFERON-positive children in whom active TB was excluded were not preventively treated for 
latent tuberculosis infection, in line with WHO recommendations [17]. 
 
The QuantiFERON-TB Gold assay was performed according to manufacturer’s instructions at the 
Global Laboratory, Ulaanbaatar, Mongolia, which participates in the QuantiFERON Quality Assurance 
Program of the Royal College of Pathologists of Australasia. Serum 25(OH)D concentrations were 
determined using an enzyme linked fluorescent assay (VIDAS 25OH Vitamin D total, Biomerieux, 
Marcy-l'Étoile, France). Total CV was 7.9%, mean bias was 7.7% and the limit of quantitation (LOQ) 
was 8.1 ng/ml. Non-zero 25(OH)D values were standardized using a set of 40 DEQAS serum samples 
as previously described by the Vitamin D Standardization Program (VDSP).[18] Values below the LOQ 
were classified as <8.1 ng/ml. Season-adjusted (deseasonalized) values were then calculated for each 
participant from their individual standardized 25(OH)D concentration and date of blood sample 
collection,  
using a sinusoidal model with values derived from standardized values for all participants [19]. 
Statistical analysis 
Data were analyzed using SAS software (version 9.4; SAS Institute, Cary, NC USA) and STATA 
(version 15; StataCorp. 2017, College Station, TX USA). Annual risk of tuberculosis infection (R) was 
estimated using the formula R = 1−(1−Prevalence)1/(mean age) [20]. The following factors were investigated 
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as risk factors for QuantiFERON-positivity, and handled as independent variables in the analysis: sex, 
age, parental education, type of residence, monthly household income, home ownership, number of 
people per room, month of sampling, number of people smoking cigarettes in the home, active smoking 
by the child, presence of BCG scar, body mass index, % body fat, household exposure to an index 
case of pulmonary tuberculosis, time spent outdoors and vitamin D deficiency, defined as serum 
25(OH)D concentration <10 ng/ml; this threshold was pre-specified, based on findings of a previous 
study that reported susceptibility to M. tuberculosis infection to be increased below this cut-off [5]. Risk 
ratios for the association between these independent variables and the dependent variable of MTB 
infection (categorized as QuantiFERON-positive vs. –negative) were estimated using generalized 
estimating equations (GEE) with the binary distribution, log link function and exchangeable working 
correlation structure [21]. When the log-binomial model failed to converge, Log-Poisson models, which 
provide consistent but not fully efficient estimates of the risk ratio and its confidence intervals, were 
used [22]. We conducted two multivariable analyses to identify factors that were independently 
associated with risk of MTB infection: one adjusted for age and sex only, and the other additionally 
adjusted for all covariates that were associated with QuantiFERON-positivity with P<0.20 in the age- 
and sex-adjusted analysis. PAFs and their 95% confidence intervals were calculated for modifiable risk 
factors for MTB infection using STATA as previously described [23]. Participants with indeterminate 
QuantiFERON results (n=4) were excluded from analyses of risk factors for MTB infection. 
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RESULTS 
 
A total of 11,475 children were invited to participate in the study from July 2015 to January 2017, of 
whom 1,065 (9.3%) declined and 596 (5.2%) were ineligible; reasons for ineligibility are presented in 
Supplementary Table 1. Socio-demographic characteristics of the remaining 9,814 children who 
participated in the study are presented in Table 1. Males and females were equally represented, mean 
age was 9.4 years and mean household income was US$ 840 per month. The BCG strains in use over 
the period of participants’ birth were Japan BCG (2001-2003), Intervax Toronto (2003-2006) and SI 
India (2007-2009). Two thousand three hundred and sixty-five (24.1%) participants lived in a centrally 
heated house or apartment, 3,774 (38.5%) lived in a house or apartment without central heating and 
3,675 (37.4%) lived in a ger (traditional Mongolian yurt). Three thousand five hundred and sixty-two 
(36.3%) participants lived in a household where at least one person smoked tobacco indoors, and 374 
(3.8%) participants had a history of household exposure to a case of pulmonary TB. Deseasonalized 
25(OH)D concentrations were available for 9,760/9,814 (99.4%) participants; they ranged from 
undetectable to 41.9 ng/ml, with a mean value of 12.1 ng/ml and standard deviation of 4.1 ng/ml. Two 
thousand four hundred and thirty-two participants (24.9%) were vitamin D deficient (25[OH]D <10 
ng/ml). 
 
Of the 9,814 children who underwent QuantiFERON testing, 8,864 (90.3%) had a negative result, 946 
(9.6%) had a positive result, and 4 (0.04%) had an indeterminate result and were excluded from 
analyses. Based on a mean participant age of 9.4 years, the annual risk of tuberculosis infection (R) 
estimated using the formula R = 1−(1−Prevalence)1/(mean age) was 1.1% [20]. Nine hundred and thirty-eight 
of the 946 QuantiFERON-positive  children (99.2%) were screened for active TB; of these, 129 (13.8%) 
were diagnosed with active TB. 
 
Table 2 presents results of univariable and multivariable analyses evaluating potential determinants of 
QuantiFERON positivity in the 9,810 participants who had a positive or negative result. The following 
factors were found to associate with increased risk of QFT-positivity after adjustment for age, sex, 
parental education, type of residence, monthly household income, home ownership, number of people 
per room, month of sampling, exposure to household environmental tobacco smoke, child active 
smoking status, household PTB contact and deseasonalized serum 25(OH)D concentration: household 
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exposure to pulmonary TB (adjusted risk ratio [aRR] 4.75, 95% CI 4.13 to 5.46), vitamin D deficiency 
(aRR 1.23, 95% CI 1.08 to 1.40), number of people smoking indoors (aRR for one indoor smoker 1.19, 
95% CI 1.04 to 1.35, aRR for two or more indoor smokers 1.30, 95% CI 1.02 to 1.64; P for trend 
=0.006) and increasing age (aRR per additional year 1.14, 95% CI 1.10 to 1.19). Population attributable 
risk fractions for modifiable risk factors for MTB infection were 13.1% for household TB contact (95% CI 
11.1% to 15.0%), 5.7% for vitamin D deficiency (95% CI 1.9% to 9.3%) and 7.2% for passive smoking 
(95% CI 2.2% to 12.0%). No independent associations were seen for sex, socio-economic indices, 
presence of a BCG scar, body mass index, % body fat or season of sampling. A sensitivity analysis 
excluding children diagnosed with active TB yielded similar results (Supplementary Table 2). 
 
In a sub-set of 373 children with a history of household exposure to an index case of pulmonary TB, 
risk of QFT-positivity was independently associated with the total number of index cases to whom the 
child had been exposed (aRR per additional index case 1.72, 95% CI 1.33 to 2.23, P<0.001) and 
increasing age (aRR per additional year 1.08, 95% CI 1.01 to 1.16, P=0.04), but not with any other 
potential risk factor investigated (Table 3). 
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DISCUSSION 
We present results of the largest and most comprehensive study investigating risk factors for MTB 
infection in children conducted to date, and the first such investigation to be done in Mongolia. In a 
representative population of schoolchildren aged 6-13 years living in the capital city, Ulaanbaatar, we 
found that household contact with a case of pulmonary TB, vitamin D deficiency, household exposure 
to environmental tobacco smoke and increasing age were independent risk factors for infection. We 
found no association between risk of MTB infection and gender, socioeconomic factors, presence of 
BCG scar, season or body mass index. 
Our study has several positive findings. The observation that MTB infection risk associates with 
household contact and increasing age is consistent with results from community-based studies and 
household contact studies in the literature [1]. The former finding emphasizes the importance of efforts 
to protect children from MTB infection in the home, and highlights the potential for a policy of household 
contact tracing with provision of preventive therapy to reduce the population-level burden of TB in low- 
and middle-income countries [17, 24, 25]. Demonstration of an independent association between 
household exposure to environmental tobacco smoke and increased risk of MTB infection suggests that 
this association is not explained by confounding due to socio-economic factors, as has previously been 
suggested [12]. The case for a causal interpretation is further supported by our demonstration of a 
dose-response relationship between increasing number of people per household smoking indoors and 
increasing risk of QuantiFERON-positivity, and by results of mechanistic studies showing that tobacco 
smoke attenuates innate immune responses to MTB both in vitro and in vivo [26-29]. Vitamin D 
metabolites have also been shown to support innate immune responses to MTB in vitro [30, 31], and 
our finding of an independent association between vitamin D deficiency and QuantiFERON-positivity 
supports the case for conducting clinical trials of vitamin D supplementation to prevent acquisition of 
MTB infection, two of which are currently in progress [14, 32].  
With regard to the magnitude of protective associations observed, we found that 13.1% of the risk of 
acquiring MTB infection was attributable to household TB contact. This figure is similar to that reported 
from a meta-analysis of ten studies which yielded an estimate of 14.1% (95% confidence interval, 
11.6%–16.3%) for the PAF for household transmission [33]. This relatively low figure reflects the fact 
that tuberculosis disease affects less than 1% of households at any time, even in high incidence 
settings, making exposure opportunities between a person with tuberculosis and their social network 
outside the household more numerous [34]. Studies in South Africa have indicated that significant 
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transmission occurs in public transportation [35] and in schools [36]. Further study to investigate sites of 
TB transmission in community settings in Mongolia is needed. The relatively high PAF for passive 
smoking (7.0%) demonstrated in our study is also striking: it highlights the importance of tobacco 
control for TB prevention [37]. The PAF for vitamin D deficiency (5.7%) echoes results of a recent 
ecological analysis, indicating that 6.3% of global variation in tuberculosis incidence is attributable to 
variations in exposure to ultraviolet-B radiation [38], which is a key determinant of vitamin D status. 
Our study also has some important null findings. In contrast to others, [2, 3] we did not find that 
presence of a BCG scar associated with protection against MTB infection. In considering the 
significance of this observation, it is important to note that absence of a BCG scar does not necessarily 
signify that BCG vaccine was not given, since a proportion of BCG-vaccinated children do not develop 
a scar. Coverage of BCG vaccination has been estimated to be as high as 98.6% in Mongolia [39]; 
thus, children without BCG scars in this study may have been vaccinated. The fact that we found no 
statistically significant association between active smoking and risk of MTB infection may be explained 
by a lack of statistical power to detect such an association, reflecting the rarity of this practice: just 
49/9810 (0.5%) participants smoked cigarettes. Accordingly, the 95% confidence interval for the risk 
ratio for active smoking was very wide (0.10 to 1.57). 
Our study has a number of strengths. Our use of the QuantiFERON test (as opposed to TST) to detect 
MTB infection allowed for MTB infection status to be evaluated without confounding by sensitization to 
BCG or environmental mycobacteria. The sample size was very large, reducing the potential for type 2 
error, and we recorded detailed information on a wide range of potential determinants of infection risk, 
allowing for comprehensive adjustment for confounders. We employed an objective assessment of 
BCG status (presence vs absence of BCG scar, evaluated by school doctors) rather than a subjective 
assessment such as eliciting a history of BCG vaccination. The lab performing QuantiFERON tests 
participated in an External Quality Assurance scheme performed by an ISO 9001-accredited laboratory, 
and rates of indeterminate results were extremely low (0.04%).  
Our study also has some limitations. As with any observational study, associations observed may be 
due to residual and/or unmeasured confounding. However, the associations that we report are all 
biologically plausible and independent, withstanding adjustment for a wide range of potential 
confounders; moreover, a dose-response relationship is seen for some risk factors (e.g. age, number of 
TB contacts, number of people per household smoking cigarettes indoors). All of these factors 
strengthen the case for causal inference. A second potential limitation is that the study was a cross-
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sectional analysis of baseline data from clinical trial participants: if this approach had resulted in 
exclusion of significant numbers of children, it could have compromised generalizability of our findings. 
However, participation rates in our study were high (85.5%), comparing favorably with those of cross-
sectional studies investigating prevalence of MTB infection in other settings [40]. A third limitation is that 
we did not test for HIV infection; however, the prevalence of HIV infection in Mongolia is very low at 
0.02% [16]. 
In conclusion, this very large, cross-sectional analysis identifies household contact with an index case 
of pulmonary TB, vitamin D deficiency and passive smoking as potentially modifiable risk factors for 
QuantiFERON-diagnosed MTB infection among Mongolian schoolchildren.  
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Table 1. Characteristics of study participants (n=9,814) 
 
Sex Female, n (%) 4,868 (49.6) 
 
Male, n (%) 4,946 (50.4) 
Mean age, years (s.d.) 9.4 (1.6) 
Parental education1 University/polytechnic, n (%) 1,881 (19.2) 
 
Secondary school or lower, n (%) 7,933 (80.8) 
Type of residence Centrally heated, n (%) 2,365 (24.1) 
 
Not centrally heated, n (%) 3,774 (38.5) 
 
Ger (Yurt) , n (%) 3,675 (37.4) 
Mean monthly household income, US dollars (s.d.)2 840 (580) 
Home ownership No, n (%) 2,114 (21.5) 
 
Yes, n (%) 7,700 (78.5) 
Mean number of people / room (s.d.) 4.7 (1.3) 
No. of people in household smoking indoors 0 6,252 (63.7) 
 1 3141 (32.0) 
 ≥2 421 (4.3) 
Child actively smoking No, n (%) 9,765 (99.5) 
 
Yes, n (%) 49 (0.5) 
Household PTB contact No, n (%) 9,440 (96.2) 
 
Yes, n (%) 374 (3.8) 
Deseasonalized serum 25(OH)D2 <10 ng/ml, n (%) 2432 (24.9) 
 ≥10 ng/ml, n (%) 7328 (75.1) 
Abbreviation: PTB, pulmonary tuberculosis; QFT, QuantiFERON®-TB Gold; s.d., standard deviation; US, United States. 
1 
Highest educational level attained by either parent 
2 
Data missing for mean monthly household income (10), Serum 25(OH)D (54) 
3 
Defined as the presence of at least one person other than the participating child smoking tobacco indoors 
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Table 2. Risk factors for QuantiFERON®-TB Gold-positivity, all participants with non-indeterminate result (n=9,810) 
Risk factors 
Proportion    QFT-
positive (%) 
Univariable analysis Adjusted for age and sex only Adjusted for age, sex and other covariates
(1)
  
Risk ratio (95% CI) P Adjusted risk ratio (95% CI) P Adjusted risk ratio (95% CI) P 
Sex 
Female 494/4867 (10.2%) 1.00 (ref) - 1.00 (ref) - 1.00 (ref)  
Male 452/4943 (9.1%) 0.90 (0.80, 1.02) 0.09 0.89 (0.79, 1.01) 0.07 0.92 (0.82, 1.04) 0.18 
Age, years - 1.17 (1.13, 1.22) <0.001 1.17 (1.13, 1.22) <0.001 1.14 (1.10, 1.19) <0.001 
Parental 
education
(2)
 
University / polytechnic  128/1881 (6.8%) 1.00 (ref) - 1.00 (ref) - 1.00 (ref)  
Secondary  school or lower 818/7929 (10.3%) 1.52 (1.27, 1.81) <0.001 1.43 (1.20, 1.71) <0.001 1.16 (0.95, 1.42) 0.14 
Type of residence 
 
Centrally heated 170/2365 (7.2%) 1.00 (ref) - 1.00 (ref) - 1.00 (ref)  
Not centrally heated  377/3772 (10.0%) 1.39 (1.17, 1.65) <0.001 1.36 (1.14, 1.62) <0.001 1.10 (0.92, 1.33) 0.29 
Ger (Yurt)  399/3673 (10.9%) 1.51 (1.27, 1.79) <0.001 1.45 (1.22, 1.72) <0.001 1.09 (0.88, 1.35) 0.41 
Monthly household income
(3)
, 100 US dollars - 0.97 (0.95, 0.99) <0.001 0.97 (0.96, 0.99) 0.003 0.99 (0.98, 1.01) 0.49 
Home ownership 
No 223/2113 (10.6%) 1.00 (ref) - 1.00 (ref) - 1.00 (ref)  
Yes 723/7697 (9.4%) 0.89 (0.77, 1.03) 0.11 0.90 (0.78, 1.03) 0.13 0.95 (0.83, 1.09) 0.48 
Number of people/room
(3)
 - 1.06 (1.03, 1.10) <0.001 1.05 (1.02, 1.09) 0.003 1.01 (0.97, 1.05) 0.63 
Month of sampling 
 
Jun-Nov 247/3259 (7.6%) 1.00 (ref) - 1.00 (ref) - 1.00 (ref)  
Dec-Feb 381/3671 (10.4%) 1.37 (1.18, 1.60) <0.001 1.31 (1.12, 1.53) <0.001 1.19 (1.00, 1.41) 0.06 
Mar-May 318/2880 (11.0%) 1.46 (1.24, 1.71) <0.001 1.45 (1.23, 1.69) <0.001 1.31 (1.10, 1.56) 0.003 
No. of people in 
household smoking 
indoors 
 
0 534/6249 (8.5%) 1.00 (ref) <0.001
(4)
 1.00 (ref) <0.001
(4)
 1.00 (ref) 0.006
(4)
 
1 347/3140 (11.1%) 1.29 (1.14, 1.47) <0.001 1.26 (1.11, 1.44) <0.001 1.19 (1.04, 1.35) 0.009 
2 or more 65/421 (15.4%) 1.81 (1.42, 2.29) <0.001 1.68 (1.33, 2.13) <0.001 1.30 (1.02, 1.64) 0.03 
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Child actively 
smoking
(3)
 
No 944/9761 (9.7%) 1.00 (ref) - 1.00 (ref) - 1.00 (ref) - 
Yes 2/49 (4.1%) 0.42 (0.11, 1.64) 0.21 0.40 (0.10, 1.54) 0.18 0.40 (0.10, 1.57) 0.19 
BCG scar 
Absent 195/1958 (10.0%) 1.00 (ref) - 1.00 (ref) -   
Present 751/7852 (9.6%) 0.96 (0.83, 1.12) 0.60 0.98 (0.84, 1.14) 0.78   
Body mass index
(3)
, kg/m
2 
 - 1.02 (0.99, 1.04) 0.17 1.00 (0.97, 1.02) 0.84 -  
Body fat
(3)
, % - 0.99 (0.98, 1.00) 0.24 1.00 (0.99, 1.01) 0.56 1.00 (ref) - 
Household PTB 
contact 
No 788/9437 (8.4%) 1.00 (ref) - 1.00 (ref) - 4.75 (4.13, 5.46) <0.001 
Yes 158/373 (42.4%) 5.07 (4.43, 5.81) <0.001 4.96 (4.33, 5.68) <0.001   
Time spent 
outdoors, 
hours / day
(3) 
 
<1 414/4120 (10.1%) 1.00 (ref) 0.17
(4)
 1.00 (ref) 0.13
(4)
 1.00 (ref) 0.56
(4)
 
1-2 290/3013 (9.6%) 0.96 (0.83, 1.10) 0.55 0.95 (0.83, 1.10) 0.49 0.96 (0.83, 1.10) 0.53 
>2 242/2677 (9.0%) 0.90 (0.77, 1.05) 0.17 0.89 (0.76, 1.03) 0.13 
0.95 (0.80, 1.12) 0.52 
Deseasonalized 
serum 25(OH)D
(3)
, 
ng/ml 
≥10 656/7325 (9.0%) 1.00 (ref) - 1.00 (ref) -   
<10 285/2431 (11.7%) 1.32 (1.16, 1.50) <0.001 1.20 (1.05, 1.37) 0.01 1.23 (1.08, 1.40) 0.002 
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; BCG, Bacille Calmette–Guérin vaccine; CI, confidence interval; PTB, pulmonary tuberculosis; QFT, QuantiFERON®-TB Gold; US, United States. 
(1)  
Adjusted for age, sex and the following covariates with P<0.2 in age/sex adjusted analysis: parental education, type of residence, monthly household income, home ownership, number of people per 
room, month of sampling, exposure to household environmental tobacco smoke, child active smoking status, household PTB contact and serum 25(OH)D concentration; 9,745 participants with non-
missing data for all covariates included in this multivariable analysis. 
(2) Highest educational level attained by either parent 
(3) Missing values (income, 10 missing; number per room, 1 missing; body mass index, 2 missing; body fat, 42 missing; 25(OH)D, 54 missing) 
(4) P-value for trend 
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Table 3. Risk factors for QuantiFERON®-TB Gold-positivity, sub-set of household pulmonary tuberculosis contacts (n=373) 
Risk factors 
Proportion      
QFT-positive (%) 
Univariable analysis 
Adjusted for age and sex only Adjusted for age, sex and other 
covariates
1
  
Risk ratio (95% CI) P Adjusted risk ratio (95% CI) P Adjusted risk ratio (95% CI) P 
Sex Female 79/185 (42.7%) 1.00 (ref) - 1.00 (ref) - 1.00 (ref) - 
 Male 79/188 (42.0%) 0.98 (0.78, 1.25) 0.89 1.00 (0.79, 1.26) 0.98 1.01 (0.80, 1.28) 0.92 
Age, years 
 
  0.02 1.09 (1.01, 1.17) 0.02 1.08 (1.01, 1.16) 0.04 
Parental education
(2)
 University / polytechnic  20/52 (38.5%) 1.00 (ref) - 1.00 (ref) - - - 
 Secondary school or lower 138/321 (43.0%) 1.12 (0.78, 1.61) 0.55 1.09 (0.76, 1.55) 0.66 - - 
Type of residence 
Centrally heated 27/74 (36.5%) 1.00 (ref) - 1.00 (ref) - 1.00 (ref) - 
Not centrally heated  51/140 (36.4%) 1.00 (0.69, 1.45) 0.99 1.00 (0.70, 1.45) 0.98 0.94 (0.65, 1.37) 0.76 
Ger (Yurt)  80/159 (50.3%) 1.38 (0.98, 1.93) 0.06 1.40 (1.00, 1.94) 0.05 1.36 (0.91, 2.03) 0.14 
Household income, 100 US dollars
(3)
 - - 0.71 1.00 (0.97, 1.02) 0.85 - - 
Home ownership 
No 45/103 (43.7%) 1.00 (ref) - 1.00 (ref) - - - 
Yes 113/270 (41.9%) 0.96 (0.74, 1.24) 0.75 0.95 (0.74, 1.24) 0.72 - - 
Number of people/room
(3)
 - - 0.10 1.05 (0.99, 1.11) 0.09 0.99 (0.92, 1.07) 0.85 
Month of sampling 
Jun-Nov 40/115 (34.8%) 1.00 (ref) - 1.00 (ref) - 1.00 (ref) - 
Dec-Feb 67/147 (45.6%) 1.31 (0.96, 1.78) 0.08 1.28 (0.94, 1.74) 0.11 1.23 (0.90, 1.67) 0.19 
Mar-May 51/111 (45.9%) 1.32 (0.96, 1.82) 0.09 1.33 (0.96, 1.83) 0.08 1.22 (0.87, 1.70) 0.25 
No. of people in 
household smoking 
indoors 
 
 
0 79/207 (38.2%) 1.00 (ref) 0.09
(5)
 1.00 (ref) 0.20
(5)
 1.00 (ref) 0.17
(5)
 
1 60/126 (47.6%) 1.25 (0.97, 1.61) 0.09 1.23 (0.96, 1.59) 0.10 1.16 (0.90, 1.50) 0.24 
2 or more 19/40 (47.5%) 1.24 (0.86, 1.80) 0.25 1.19 (0.82, 1.73) 0.35 1.19 (0.83, 1.73) 0.35 
BCG scar 
Absent 24/66 (36.4%) 1.00 (ref) - 1.00 (ref) - - - 
Present 134/307 (43.6%) 1.20 (0.85, 1.69) 0.30 1.19 (0.85, 1.68) 0.31 - - 
Body mass index, kg/m
2
 - 1.01 (0.97, 1.05) 0.73 0.99 (0.95, 1.04) 0.78 - - 
Body fat, %
(3)
  - 0.99 (0.96, 1.01) 0.32 0.99 (0.96, 1.01) 0.34 - - 
Number of PTB index cases - 1.62 (1.32, 2.00) <0.001 1.58 (1.27, 1.96) <0.001 1.72 (1.33, 2.23) <0.001 
Deseasonalized serum 
25(OH)D, ng/ml
(3)
 
≥10 113/280 (40.4%) 1.00 (ref) - 1.00 (ref) -  - 
<10 44/91 (48.4%) 1.20 (0.93, 1.55) 0.17 1.14 (0.87, 1.48) 0.35   
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; BCG, Bacille Calmette–Guérin vaccine; CI, confidence interval; PTB, pulmonary tuberculosis; QFT, QuantiFERON®-TB Gold; US, United State 
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(1) 
Adjusted for age, sex and the following covariates with P<0.2 in age/sex adjusted analysis: type of residence, number of people per room, month of sampling, household environmental tobacco smoke, 
number of PTB index cases and serum 25(OH)D; 370 participants with non-missing data for all covariates were included in this multivariable analysis. 
(2) 
Highest educational level attained by either parent 
(3) 
Missing values (income, 1 missing; number per room, 1 missing; body fat, 2 missing; 25(OH)D, 2 missing) 
(4) Defined as the presence of at least one person other than the participating child smoking indoors 
(5) P-value for trend 
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